Anti-Human CD4 Recombinant Antibody(Zanolimumab)

Product Information

Catalog Number	YR1135
Product Name	Anti-Human CD4 Recombinant Antibody(Zanolimumab)
Molecular Name	Zanolimumab
Alias	Anti-CD4 Recombinant Antibody, Research Grade Zanolimumab
CAS Number	652153-01-0
Target	CD4[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	Neut, ELISA, IF, IP, FuncS, FCM
Buffer	PBS, pH7.5
Background	Zanolimumab (expected trade name HuMax-CD) is a human monoclonal antibody and an immunosuppressive drug. It was developed with the goal of treatment of rheumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma. Development of the drug was ultimately discontinued with termination of all trials.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price